Annual Short Term Debt
$58.00 K
-$52.00 K-47.27%
31 December 2023
Summary:
GT Biopharma annual short term debt is currently $58.00 thousand, with the most recent change of -$52.00 thousand (-47.27%) on 31 December 2023. During the last 3 years, it has fallen by -$26.28 million (-99.78%). GTBP annual short term debt is now -99.78% below its all-time high of $26.33 million, reached on 31 December 2020.GTBP Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$0.00
$0.000.00%
30 September 2024
Summary:
GT Biopharma quarterly short term debt is currently $0.00, unchanged on 30 September 2024. Over the past year, it has dropped by -$92.00 thousand (-100.00%). GTBP quarterly short term debt is now -100.00% below its all-time high of $26.33 million, reached on 31 December 2020.GTBP Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTBP Short Term Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -47.3% | -100.0% |
3 y3 years | -99.8% | -100.0% |
5 y5 years | -99.5% | -100.0% |
GTBP Short Term Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -99.8% | +87.1% | -100.0% | |
5 y | 5 years | -99.8% | +87.1% | -100.0% | |
alltime | all time | -99.8% | +87.1% | -100.0% |
GT Biopharma Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $0.00(0.0%) |
June 2024 | - | $0.00(-100.0%) |
Mar 2024 | - | $30.00 K(-48.3%) |
Dec 2023 | $58.00 K(-47.3%) | $58.00 K(-37.0%) |
Sept 2023 | - | $92.00 K(-23.3%) |
June 2023 | - | $120.00 K(+3.4%) |
Mar 2023 | - | $116.00 K(+5.5%) |
Dec 2022 | $110.00 K(+254.8%) | $110.00 K(+3.8%) |
Sept 2022 | - | $106.00 K(+2.9%) |
June 2022 | - | $103.00 K(+3.0%) |
Mar 2022 | - | $100.00 K(+222.6%) |
Dec 2021 | $31.00 K(-99.9%) | $31.00 K(0.0%) |
Sept 2021 | - | $31.00 K(0.0%) |
June 2021 | - | $31.00 K(0.0%) |
Mar 2021 | - | $31.00 K(-99.9%) |
Dec 2020 | $26.33 M(+97.1%) | $26.33 M(+13.9%) |
Sept 2020 | - | $23.11 M(+5.2%) |
June 2020 | - | $21.96 M(+64.0%) |
Mar 2020 | - | $13.39 M(+0.3%) |
Dec 2019 | $13.36 M(+23.6%) | $13.36 M(+0.4%) |
Sept 2019 | - | $13.31 M(+7.8%) |
June 2019 | - | $12.35 M(+7.5%) |
Mar 2019 | - | $11.49 M(+6.3%) |
Dec 2018 | $10.80 M(>+9900.0%) | $10.80 M(+1.7%) |
Sept 2018 | - | $10.63 M(+54.3%) |
June 2018 | - | $6.89 M(+132.4%) |
Mar 2018 | - | $2.96 M(+9458.1%) |
Dec 2017 | $31.00 K(-99.8%) | $31.00 K(0.0%) |
Sept 2017 | - | $31.00 K(-99.8%) |
June 2017 | - | $12.42 M(+5.3%) |
Mar 2017 | - | $11.79 M(-5.0%) |
Dec 2016 | $12.41 M(+37.4%) | $12.41 M(+14.0%) |
Sept 2016 | - | $10.89 M(+8.1%) |
June 2016 | - | $10.07 M(+0.5%) |
Mar 2016 | - | $10.03 M(+11.0%) |
Dec 2015 | $9.03 M(+231.5%) | $9.03 M(+137.2%) |
Sept 2015 | - | $3.81 M(+29.0%) |
June 2015 | - | $2.95 M(+1.4%) |
Mar 2015 | - | $2.91 M(+6.8%) |
Dec 2014 | $2.73 M(+9.4%) | $2.73 M(+0.7%) |
Sept 2014 | - | $2.71 M(+1.4%) |
June 2014 | - | $2.67 M(+2.7%) |
Mar 2014 | - | $2.60 M(+4.3%) |
Dec 2013 | $2.49 M(+32.5%) | $2.49 M(+9.7%) |
Sept 2013 | - | $2.27 M(+4.8%) |
June 2013 | - | $2.17 M(+12.6%) |
Mar 2013 | - | $1.93 M(+2.4%) |
Dec 2012 | $1.88 M(-8.8%) | $1.88 M(-29.9%) |
Sept 2012 | - | $2.68 M(+21.5%) |
June 2012 | - | $2.21 M(+0.2%) |
Mar 2012 | - | $2.20 M(+6.7%) |
Dec 2011 | $2.06 M(-4.8%) | $2.06 M(+940.9%) |
Sept 2011 | - | $198.00 K(-90.5%) |
June 2011 | - | $2.09 M(+2.7%) |
Mar 2011 | - | $2.04 M(-5.8%) |
Dec 2010 | $2.16 M | $2.16 M(+22.3%) |
Sept 2010 | - | $1.77 M(-8.4%) |
Date | Annual | Quarterly |
---|---|---|
June 2010 | - | $1.93 M(-8.3%) |
Mar 2010 | - | $2.11 M(-0.9%) |
Dec 2009 | $2.13 M(-1.1%) | $2.13 M(-7.4%) |
Sept 2009 | - | $2.29 M(+4.5%) |
June 2009 | - | $2.19 M(+1.7%) |
Mar 2009 | - | $2.16 M(+0.5%) |
Dec 2008 | $2.15 M(-29.8%) | $2.15 M(+0.2%) |
Sept 2008 | - | $2.14 M(+99.5%) |
June 2008 | - | $1.07 M(+11.2%) |
Mar 2008 | - | $966.00 K(-68.4%) |
Dec 2006 | $3.06 M(0.0%) | $3.06 M(-13.7%) |
Sept 2006 | - | $3.54 M(-3.1%) |
June 2006 | - | $3.66 M(0.0%) |
Mar 2006 | - | $3.66 M(+19.6%) |
Dec 2005 | $3.06 M(+125.0%) | $3.06 M(+1812.5%) |
Mar 2005 | - | $160.00 K(-88.2%) |
Dec 2004 | $1.36 M(+750.0%) | $1.36 M(-22.9%) |
Sept 2004 | - | $1.76 M(+8.8%) |
June 2004 | - | $1.62 M(+481.0%) |
Mar 2004 | - | $279.00 K(+74.4%) |
Dec 2003 | $160.00 K(0.0%) | $160.00 K(0.0%) |
Sept 2003 | - | $160.00 K(0.0%) |
June 2003 | - | $160.00 K(0.0%) |
Mar 2003 | - | $160.00 K(0.0%) |
Dec 2002 | $160.00 K(-36.5%) | $160.00 K(-3.6%) |
Sept 2002 | - | $166.00 K(-8.3%) |
June 2002 | - | $181.00 K(-12.6%) |
Mar 2002 | - | $207.00 K(-17.9%) |
Dec 2001 | $252.00 K(-2.7%) | $252.00 K(-11.3%) |
Sept 2001 | - | $284.00 K(-3.7%) |
June 2001 | - | $295.00 K(+13.9%) |
Mar 2001 | - | $259.00 K(0.0%) |
Dec 2000 | $259.00 K(-66.6%) | $259.00 K(-52.1%) |
Sept 2000 | - | $541.00 K(0.0%) |
June 2000 | - | $541.00 K(-0.2%) |
Mar 2000 | - | $542.00 K(-30.1%) |
Dec 1999 | $775.00 K(-3.1%) | $775.00 K(+10.7%) |
Sept 1999 | - | $700.00 K(-12.5%) |
June 1999 | - | $800.00 K(0.0%) |
Mar 1999 | - | $800.00 K(0.0%) |
Dec 1998 | $800.00 K(-46.7%) | $800.00 K(0.0%) |
Sept 1998 | - | $800.00 K(-20.0%) |
June 1998 | - | $1.00 M(-33.3%) |
Mar 1998 | - | $1.50 M(0.0%) |
Dec 1997 | $1.50 M(+15.4%) | $1.50 M(+25.0%) |
Sept 1997 | - | $1.20 M(0.0%) |
June 1997 | - | $1.20 M(-20.0%) |
Mar 1997 | - | $1.50 M(+15.4%) |
Dec 1996 | $1.30 M(-31.6%) | $1.30 M(+225.0%) |
Sept 1996 | - | $400.00 K(-20.0%) |
June 1996 | - | $500.00 K(-73.7%) |
Mar 1996 | - | $1.90 M(0.0%) |
Dec 1995 | $1.90 M(+137.5%) | $1.90 M(+11.8%) |
Sept 1995 | - | $1.70 M(-5.6%) |
June 1995 | - | $1.80 M(+28.6%) |
Mar 1995 | - | $1.40 M(+75.0%) |
Dec 1994 | $800.00 K | $800.00 K(+60.0%) |
Sept 1994 | - | $500.00 K |
FAQ
- What is GT Biopharma annual short term debt?
- What is the all time high annual short term debt for GT Biopharma?
- What is GT Biopharma annual short term debt year-on-year change?
- What is GT Biopharma quarterly short term debt?
- What is the all time high quarterly short term debt for GT Biopharma?
- What is GT Biopharma quarterly short term debt year-on-year change?
What is GT Biopharma annual short term debt?
The current annual short term debt of GTBP is $58.00 K
What is the all time high annual short term debt for GT Biopharma?
GT Biopharma all-time high annual short term debt is $26.33 M
What is GT Biopharma annual short term debt year-on-year change?
Over the past year, GTBP annual short term debt has changed by -$52.00 K (-47.27%)
What is GT Biopharma quarterly short term debt?
The current quarterly short term debt of GTBP is $0.00
What is the all time high quarterly short term debt for GT Biopharma?
GT Biopharma all-time high quarterly short term debt is $26.33 M
What is GT Biopharma quarterly short term debt year-on-year change?
Over the past year, GTBP quarterly short term debt has changed by -$92.00 K (-100.00%)